[English] 日本語
Yorodumi- PDB-1c6y: ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT H... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 1c6y | ||||||
|---|---|---|---|---|---|---|---|
| Title | ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESULT OF CONCERTED STRUCTURAL CHANGE IN 80'S LOOP. | ||||||
 Components | PROTEIN (PROTEASE) | ||||||
 Keywords | HYDROLASE | ||||||
| Function / homology |  Function and homology information | ||||||
| Biological species | ![]()  Human immunodeficiency virus 1 | ||||||
| Method |  X-RAY DIFFRACTION / Resolution: 2.5 Å  | ||||||
 Authors | Munshi, S. | ||||||
 Citation |  Journal: Acta Crystallogr.,Sect.D / Year: 2000Title: An alternate binding site for the P1-P3 group of a class of potent HIV-1 protease inhibitors as a result of concerted structural change in the 80s loop of the protease. Authors: Munshi, S. / Chen, Z. / Yan, Y. / Li, Y. / Olsen, D.B. / Schock, H.B. / Galvin, B.B. / Dorsey, B. / Kuo, L.C. #1:   Journal: J.Biol.Chem. / Year: 1994Title: Crystal Structure at 1.9-A Resolution of Human Immunodeficiency Virus (HIV) II Protease Complexed with L-735,524, an Orally Bioavailable Inhibitor of the HIV Proteases Authors: Chen, Z. / Li, Y. / Chen, E. / Hall, D.L. / Darke, P.L. / Culberson, C. / Shafer, J.A. / Kuo, L.C.  | ||||||
| History | 
  | 
-
Structure visualization
| Structure viewer | Molecule:  Molmil Jmol/JSmol | 
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format |  1c6y.cif.gz | 53.3 KB | Display |  PDBx/mmCIF format | 
|---|---|---|---|---|
| PDB format |  pdb1c6y.ent.gz | 38.6 KB | Display |  PDB format | 
| PDBx/mmJSON format |  1c6y.json.gz | Tree view |  PDBx/mmJSON format | |
| Others |  Other downloads | 
-Validation report
| Summary document |  1c6y_validation.pdf.gz | 483.2 KB | Display |  wwPDB validaton report | 
|---|---|---|---|---|
| Full document |  1c6y_full_validation.pdf.gz | 486.5 KB | Display | |
| Data in XML |  1c6y_validation.xml.gz | 6.3 KB | Display | |
| Data in CIF |  1c6y_validation.cif.gz | 9.3 KB | Display | |
| Arichive directory |  https://data.pdbj.org/pub/pdb/validation_reports/c6/1c6y ftp://data.pdbj.org/pub/pdb/validation_reports/c6/1c6y | HTTPS FTP  | 
-Related structure data
-
Links
-
Assembly
| Deposited unit | ![]() 
  | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 
  | ||||||||
| Unit cell | 
  | 
-
Components
| #1: Protein | Mass: 10801.674 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Details: NY5 ISOLATE / Source: (gene. exp.) ![]()  Human immunodeficiency virus 1 / Genus: Lentivirus / Gene: NY5 ISOLATE / Production host: ![]() References: UniProt: O09893, Hydrolases; Acting on peptide bonds (peptidases); Metalloendopeptidases #2: Chemical |  ChemComp-MK1 /  | #3: Water |  ChemComp-HOH /  | Nonpolymer details | L-735,524 IS N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)- TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL) ...L-735,524 IS N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)- TERTIARY BUTYLAMINO |  | 
|---|
-Experimental details
-Experiment
| Experiment | Method:  X-RAY DIFFRACTION | 
|---|
-
Sample preparation
| Crystal | Density Matthews: 2.56 Å3/Da / Density % sol: 51.98 % | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Crystal grow | Details: THE CRYSTAL WAS PREPARED WITH CO CRYSTALLIZATION METHOD. 9X MUTANT PROTEASE HAS NINE POINT MUTATIONS COMPARED TO WILD TYPE: L10V,K20M,L24I,S37D,M46I,I54V,L63P,A71V,V82T THERE IS ONE PROTEASE ...Details: THE CRYSTAL WAS PREPARED WITH CO CRYSTALLIZATION METHOD. 9X MUTANT PROTEASE HAS NINE POINT MUTATIONS COMPARED TO WILD TYPE: L10V,K20M,L24I,S37D,M46I,I54V,L63P,A71V,V82T THERE IS ONE PROTEASE DIMER IN AN ASYMMETRICAL UNIT. THE TWO MOLECULES ARE LABELED AS CHAIN A AND CHAIN B. THERE IS ONE L-735,524 INHIBITOR MOLECULE LABELED AS MK1. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Crystal grow | *PLUS pH: 5  / Method: otherDetails: inhibitor-protein mixture and the reservoir solution were mixed in a 1:1(v/v) ratio  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Components of the solutions | *PLUS 
  | 
-Data collection
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray | 
|---|---|
| Radiation wavelength | Relative weight: 1 | 
| Reflection | Num. all: 35099 / Num. obs: 7254 / % possible obs: 89 % / Rmerge(I) obs: 0.052 | 
| Reflection shell | Resolution: 2.5→2.59 Å / % possible all: 84 | 
| Reflection | *PLUS Highest resolution: 2.5 Å / Lowest resolution: 20 Å / Num. measured all: 35099  | 
| Reflection shell | *PLUS % possible obs: 84 % / Num. unique obs: 676  / Num. measured obs: 1775  / Rmerge(I) obs: 0.165  / Mean I/σ(I) obs: 4.4  | 
-
Processing
| Software | Name:  X-PLOR / Classification: refinement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Resolution: 2.5→8 Å / Rfactor Rfree: 0.31 / Rfactor Rwork: 0.18 / Rfactor obs: 0.18 / σ(F): 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: LAST / Resolution: 2.5→8 Å
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints | 
  | 
Movie
Controller
About Yorodumi




Human immunodeficiency virus 1
X-RAY DIFFRACTION
Citation






















PDBj




